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Towards S. aureus MALDI-typing:  
Genotypic Correlation and Shotgun Proteomic Identification 
Dania Awad 
Abstract 
Staphylococcus aureus is possibly the most common human pathogen causing 
approximately one third of all bacteria-related diseases. S. aureus’ adaptable characteristics 
and increasing antibiotic resistance allows it to thrive in both nosocomial and community 
settings. Identification of S. aureus is mainly performed via phenotypic methods and costly 
genotypic methods. Recently, Matrix Assisted Laser Desorption Ionization-Time of Flight 
Mass Spectrometry (MALDI-TOF MS) has been introduced into clinical microbiology as 
a means of bacterial identification to the species level. In this study, we compared MALDI 
protein fingerprints to genomic data of 25 S. aureus isolates, an S. epidermidis strain and 
an E. coli strain finding only geographic separation as visualized in a dendrogram. The 
absence of correlation between genomic and proteomic data to the strain level is owed to 
genomic mutations leading to protein isomers being falsely identified as different proteins 
at the MALDI level. Tryptic digests of protein extracts from one isolate were further 
characterized by NanoFlow Liquid Chromatography coupled with MALDI-TOF MS/MS 
and 94 proteins were successfully identified. Three candidate proteins are proposed for 
MALDI-TOF MS typing, which marks a step towards fast identification of S. aureus to the 
strain level via MALDI-TOF MS. 
Keywords: Proteomics, Staphylococcus aureus, Matrix Assisted Laser Desorption 
Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS), NanoFlow Liquid 
Chromatography, typing.  
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Chapter One 
 
 Introduction 
1.1 Staphylococcus aureus 
Staphylococcus aureus is a gram-positive, facultative anaerobe bacterium. All 
members of the genus Staphylococcus are non-motile, none-sporing cocci, which form 
grape-like clusters upon division. The species’ name aureus refers to the golden 
colonies that appear on solid agar. Nearly all strains of S. aureus are catalase-positive 
and coagulase-positive, important characteristics exploited in S. aureus identification 
(Harris, Foster, & Richards, 2002). 
S. aureus is common in both community and nosocomial (hospital-related) 
settings. The ability of S. aureus to thrive in a community setting is related to its 
adaptable characteristics, since S. aureus is part of the normal human flora. On the 
other hand, the antibiotic resistance mechanisms have opened the path for S. aureus to 
enter and survive in nosocomial settings (Zetola, Francis, Nuermberger, & Bishai, 
2005). S. aureus causes one of the most common nosocomial infections; its 
complications have high mortality rates due to bacteremia (Lark et al., 2001). Due to 
the increasing use of antibiotics, multiple drug resistant S. aureus strains have 
emerged; making it a major pathogen of interest (Lowy, 2000). Also, due to different 
selective pressures between nosocomial and community settings, isolates of each differ 
notably (Zetola, Francis et al. 2005).  
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1.1.1 S. aureus Virulence 
S. aureus is possibly the most common human pathogen; it causes around one 
third of all bacterial diseases, which range from mild pus-forming superficial lesions 
(boils, styes and furuncles) to more serious colonization of internal organs (mastitis, 
phlebitis, meningitis, urinary tract infections, osteomyelitis and endocarditis).  
Pathogenicity is due to the many potential virulence factors of S. aureus, which 
include: (1) surface proteins that promote colonization of host tissues; (2) invasins that 
promote bacterial spread in tissues (leukocidin, kinases, hyaluronidase); (3) surface 
factors that inhibit phagocytic engulfment (capsule, Protein A); (4) biochemical 
properties that enhance their survival in phagocytes (carotenoids, catalase production); 
(5) immunological membranes (hemolysins, leukotoxin, leukocidin); (6) exotoxins 
that damage host tissues or provoke symptoms of disease (SEA-G, TSST, ET); and (7) 
inherent and acquired resistance to antimicrobial agents (Todar 2009).   
Secreted virulence factors play a major role in host pathogenesis. Type VII 
secretion system (T7SS) in S. aureus secretes virulence factors EsxA and EsxB to the 
extracellular surroundings. While EsxB is required for EsxA synthesis, EsxA (Ess 
extracellular A) is involved in abscess formation process of pathogenesis (Burts, 
Williams, DeBord, & Missiakas, 2005); (Sundaramoorthy, Fyfe, & Hunter, 2008). 
Additionally, basic S. aureus cell physiology is linked to its pathogenicity; it was 
recently shown that tricarboxylic acid cycle activity contributes to its virulence 
(Meyer, Liebeke, & Lalk, 2010). 
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1.2 Bacterial Identification 
Successful elimination of a suspected bacterial infection in a patient requires 
the identification of the pathogen at hand and employing the best antibiotic treatment 
available, accordingly (Carbonnelle et al., 2011). In addition to pathogen 
identification, microbial typing methods offer us a better understanding of microbial 
population epidemiology and diversity (Boers, van der Reijden, & Jansen, 2012). The 
choice of typing method is usually dependent on the aim of investigation, and other 
factors including: discriminatory power, reproducibility, technical difficulty, time, 
throughput and cost (Boers et al., 2012). 
In general, bacterial species are identified using conventional methods, based 
on physiology as well as biochemistry. These methods rely on cell structure, cellular 
metabolism, and pigments for identification. However, these methods lack both 
specificity and sensitivity, and are time-consuming. One limitation of these methods is 
caused by differential expression of phenotypic features among different isolates of 
the same species (Yang et al., 2009). Moreover, human error associated with the 
interpretation of some tests may compromise objectiveness (Hussain et al., 2008). 
1.2.1 Typing of S. aureus 
Strain identification of S. aureus is mainly performed via pulse field gel 
electrophoresis (PFGE), spa, Multilocus sequence typing (MLST),  multilocus 
variable number of tandem repeat analysis (MLVA), and repeat-element PCR typing 
(Tang, 2009). These genetic typing methods are distinguished by their high 
discriminatory power, however, these methods remain cost intensive, time consuming, 
and tedious (Yang et al. 2009). Accordingly, an increasing need arises for methods 
with high sensitivity, specificity, speed, reproducibility and reliability for S. aureus 
identification (Yang et al. 2009). 
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1.3 Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectrometry 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry is 
a gentle ionization method capable of detecting and characterizing biopolymers such 
as peptides, proteins, oligosaccharides and nucleotides (Kaufmann, 1995). 
1.3.1 Bacterial Identification via MALDI TOF MS 
Bacterial identification via MALDI-TOF MS is based on the examination of 
sample protein contents, identification and detection of protein biomarkers that are 
unique to a specific bacterium (Cherkaoui et al., 2010). Mass spectrometry is a 
promising technique for routine bacterial identification in clinical microbiology 
(Anhalt & Fenselau, 1975); (Carbonnelle et al., 2007); (Degand et al., 2008); (Seng et 
al., 2009). 
MALDI-TOF MS has a rapid turnaround time, low sample volume 
requirements and modest reagent costs. Samples can be prepared in a few minutes 
while data acquisition can be acquired in a few seconds. Identification of different 
bacterial species by MALDI-TOF MS has been proven to be successful, rapid, and 
accurate (S. Y. Hsieh et al., 2008) (Rajakaruna et al., 2009) (Sauer & Kliem, 2010) 
(Seng et al., 2009).  By comparing MALDI-TOF MS results to multilocus variable-
number tandem repeat analysis (MLVA) data, Lista and Reubsaet were able to 
correctly identify Brucella species in 99.3% of 152 Brucella isolates using MALDI-
TOF MS (Lista et al., 2011). 
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1.3.2 S. aureus Typing via MALDI-TOF MS 
Liu and Du developed a universal method for S. aureus identification by 
MALDI-TOF MS that is rapid, simple, and highly reproducible.  This identification 
method was able to discriminate between E. coli and S. aureus, based on the unique 
spectral profiles generated by each, in a mass range of 1,000 to 20,000 Da (Liu, Du, 
Wang, & Yang, 2007). Furthermore, Du et al. was capable of differentiating between 
methicillin-resistant Staphylococcus aureus (MSSA) and methicillin-susceptible S. 
aureus (MRSA) with the use of MALDI-TOF MS (Du, Yang, Guo, Song, & Wang, 
2002). 
To take appropriate measures during an epidemiological outbreak, it is of great 
importance to differentiate among infections resulting from strains of the same clonal 
complex and strains of different clonal origin. For this reason, clinical isolates of S. 
aureus were collected during an epidemiological outbreak from a single hospital ward. 
Upon comparison of the isolates' spectra, a common peak pattern was observed. 
Moreover, additional S. aureus isolates were collected from different hospital wards 
and upon the comparison of the isolates' spectra, significant variations were apparent 
between spectra of isolates collected from different hospital wards (Bernardo et al., 
2002). 
1.3.3 Typing via MALDI-TOF MS and Bruker Biotyper 
When MALDI-TOF MS and Bruker biotyper are coupled, the result is rapid 
identification of bacterial isolates. While MALDI-TOF MS generates spectral profiles 
of bacterial proteins, Bruker biotyper references these spectra to a compiled database, 
thus allowing bacterial identification to the genus and species level. Bruker Biotyper 
work is based on pattern matching of MALDI-generated spectra to library spectra 
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(Saffert et al., 2011). Additionally, Bruker Biotyper is capable of constructing a 
hierarchical dendrogram, based on spectral similarities and differences among 
submitted isolates (Tani et al., 2012).  
In 2010, Szabados and Woloszyn employed Bruker Biotyper in the 
identification of 602 molecularly defined S. aureus isolates and 412 isolates that 
belong to different Staphylococci species other than S. aureus. Identification accuracy 
was 100% for both pools of isolates. Continual growth, by user supplementation and 
software updates of Bruker Biotyper library, continue to better MALDI-TOF MS and 
Biotyper-based bacterial identification (Theel, Hall, Mandrekar, & Wengenack, 2011). 
 
1.4 Protein Identification  
Identification of S. aureus proteome allows for better understanding of 
MALDI-TOF MS spectra, thus improving MALDI-TOF MS-typing efficiency. The 
need to characterize complex proteomic mixtures led to the coupling of mass 
spectrometry with liquid chromatography techniques (Moon, Myung, Plasencia, 
Hilderbrand, & Clemmer, 2003). This bottom up approach consists of two steps: 
peptides fractionation via LC followed by peptides fragmentation via MS/MS (Kocher, 
Pichler, Swart, & Mechtler, 2012). Protein identities are then obtained by matching 
resulting MS/MS spectra with proteomic databases, which contain in-silico digests and 
in-silico fragments (Cottrell, 2011).  
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1.4.1 NanoFlow LC MS/MS 
The use of narrow-bore LC capillaries operated at ultralow flow rates coupled 
with tandem mass spectrometry results with protein identification, which is 
characterized with  in-depth protein sequence coverage and high rate of data 
production (F. Zhou, Lu, Ficarro, Webber, & Marto, 2012).  Reverse-phase (RP) LC 
is most commonly used in shotgun proteomics; whereby mobile phase polarity is 
gradually decreased by the addition of organic solvent (E. J. Hsieh, Bereman, Durand, 
Valaskovic, & MacCoss, 2013).   
Collision Induced Dissociation of peptides, achieved by dual time of flight 
MALDI MS, results with MS/MS spectra composed of product ion patterns. Ion 
products are dependent on both, the peptide sequence and instrument used (Khatun, 
Ramkissoon, & Giddings, 2007). A database search of un-interpreted MS/MS spectral 
raw data culminates the process of protein identification.  
 
In this study, we attempt to correlate proteomic profiles of S. aureus isolates 
with their corresponding genotypic characteristics. In addition, we carried out shotgun 
proteomics on formic acid extracts of one S. aureus isolate to identify S. aureus 
proteins of typable quality. 
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Chapter Two 
 
 Materials and Methods 
2.1 Clinical Isolates: 
 This study was conducted on a total of twenty-five isolates of S. aureus 
collected from clinical specimens and provided by Dr. Sima Tokajian. Thirteen of the 
twenty-five isolates originated from the Jordan University Hospital (JUH) in Amman, 
accordingly isolates were designated JS ##. The other twelve isolates originated from 
the American University in Beirut-Medical Center (AUB-MC), accordingly 
designated LS ##. SCCmec types, MLST types, spa types, and PVL virulence were 
previously characterized for all isolates, by senior colleagues. A detailed view of the 
isolates and their characteristics are listed in Table 2.1. Additionally, one strain of 
Staphylococcus epidermidis (S. epidermidis) ATCC 12228 and another of Escherichia 
coli (E. coli) ATCC 25922 were included in this study. Isolate LS 16 was chosen for 
further peptide analysis and protein identification. S. aureus isolates involved in this 
study have been previously thoroughly studied by Harastani et al. (2013) and Al-Bakri 
et al. (2013). 
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Table 2.1. A detailed view of characteristics of S. ausreus isolates utilized in this study (Harastani et al. (2013) and Al-Bakri et al. (2013)). 
Sample ID mecA type PVL MLST-ST type MLST-CC spa type spa-CC Site of Infection 
JS 003 MSSA - ST-046 CC045 t 0065 CC0065 Nose 
JS 008 MRSA-IV - ST-025 CC005 t 0922 Singletons Nose 
JS 010 MSSA - ST-005 CC005 t 0002 CC0214 Nose 
JS 017 MSSA - ST-006 CC005 t 0701 CC0024/CC0701 Stool 
JS 022 MSSA - ST-022 CC022 t 0005 CC0223 Nose 
JS 050 MRSA-IV - ST-395 CC395 t 1651 No Founder Nose 
JS 052 MSSA - ST-30 CC030 t 0012 CC0012 Nose 
JS 054 MSSA - ST-015 CC015 t 0084 CC0346/CC2398/CC0084 Nose 
JS 056 MSSA - ST-008 CC008 t 0024 CC0024/CC0701 Stool 
JS 060 MRSA-IV + - - t 0044 CC0044 Stool 
JS 061 MSSA - ST-001 CC001 t 0267 Singletons Nose 
JS 065 MSSA - ST-097 CC097 t 0166 Singletons Nose 
JS 085 MSSA - ST-034 CC030 t 5842 No Founder Stool 
LS 016 MRSA-IV + ST-030 CC030 t 0318 CC0021 Wound 
LS 024 MRSA-III - ST-239 CC239 t 0037 CC0021 Brain 
LS 034 MRSA-V - ST-097 CC097 t 0267 Singletons Neck mucus 
LS 036 MRSA-III - ST-239 CC239 t 0030 CC0021 Wound 
LS 057 MRSA-IV + ST-080 CC080 t 0131 CC0044 Eye 
LS 079 MSSA - ST-005 CC005 t 0002 CCb Blood 
LS 089 MSSA - ST-080 CC080 t 0937 CCd Wound 
LS 094 MSSA - ST-030 CC030 t 0012 CC0021 Blood 
LS 098 MSSA + ST-121 CC121 t 0159 Singletons Bronchi 
LS 103 MRSA-IV - ST-022 CC022 t 0032 CC0005 Sputum 
LS 125 MRSA-IV + ST-005 CC005 t 0311 CCb Sputum 
LS 126 MRSA-IV - ST-008 CC008 t 0008 CC0008 Semen 
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2.2 Protein Extraction: 
Formic acid extraction of S. aureus proteins was performed according to 
Wolters et. al (2011) with few modifications. Accordingly, S. aureus isolates were 
cultured on TSA plates and incubated at a temperature of 37 ⁰C for 22-24 hrs. A full 
loop of colonies was suspended in 300 µL of HPLC-grade water. Vigorous vortexing 
followed the addition of 900 µL of ethanol. Cell lysate was then centrifuged at 
12,000×g for 2 min at room temperature. After discarding the supernatant, 
centrifugation was repeated to remove any residual ethanol. Then, the pellet was 
resuspended in 50 μL of 70% formic acid. This step was followed by the addition of 
50 μL of ACN.  A 10 min vigorous vortexing followed the addition of each, formic 
acid and ACN.  Centrifugation was applied at 20,000×g for 2 min. From the 
supernatant, 80 μL were collected and stored at −20 °C. Three biological replicates 
were collected for each S. aureus isolate. 
 
2.3 Protein Quantification: 
 Prior to protein quantification, protein extracts were dried using a speedvac and 
reconstituted in HPLC-grade water. Protein quantification was carried out using a 
Pierce BCA Protein Assay Kit (p/n: 23337, Thermo Scientific). Absorbance 
measurements were recorded at a wavelength of 595 nm using a Multi-scan micro-
plate reader (Thermo Scientific). A standard curve was generated based on absorbance 
measurements of serial dilutions of Bovine Serum Albumin (250, 125, 50, 25, 5, and 
0 µg/mL). After linear regression analysis, protein concentrations were computed. 
Readings for standard and biological extracts were taken in triplicates. Concentrations 
of 25 S. aureus, S. epidermidis, E. coli and LS 16 protein extracts were determined 
accordingly.  
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2.4 In-Solution Tryptic Digestion 
In-solution tryptic digestion protocol was adopted from the mass spectrometry 
department of University of California in San Francisco (UCSF). A total of 1,000 µL 
of LS 16 protein extract was dried via Speed Vac and reconstituted in 50 mM 
NH4HCO3. Reduction was attained by the addition of 100 µL of 100 mM DTT and 
sequential incubations at 95 ᵒC for 5 min and 60 ᵒC for 30 min. Then, alkylation 
proceeded with the addition of 200 uL of 55 mM iodoacetamide and dark incubation 
at room temperature for 20 min. Protein extract was then treated with 100 µL (0.1 
µg/µL) of fresh TCPK-treated trypsin solution (p/n: t1426, Sigma-Aldrich). Digestion 
took place at 37 ᵒC for 3 hrs and was terminated by placing peptides on ice.   
 
2.5 Nano-Flow Liquid Chromatography 
2.5.1 NanoFlow LC Set Up 
Peptide separation was carried out on an Agilent 1260 Infinity Nanoflow 
Liquid Chromatography System. NanoLC system consisting of 8 modules: Solvent 
Cabinet, Micro Vacuum Degasser, Binary Nanoflow Pump, High Performance Micro 
Autosampler, Autosampler Thermostat, Thermostatted Column Compartment, 
Multiple Wavelength Detector, and Micro-scale Fraction Collector/Spotter. The 
NanoLC system was operated by ChemStation software version B.04.03-SP1 (Agilent 
Technologies, USA). 
The NanoLC system configuration was set to deliver peptides directly on a 
nanobore trapping column (Agilent Technologies, Zorbax SB300-C18 0.75 µm x 
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150 mm, 3.5 µm). The total dead volume of the NanoLC system was measured using 
acetone to be 2.5 µL.  
Needle washes preceded every NanoLC run for 30 sec using 15% methanol 
84% HPLC-grade water and 0.1% formic acid solution. Solvent A bottle contained 
HPLC-grade water and solvent B bottle contained ACN. Both solvents were freshly 
prepared and filtered using 0.45 µm filters (Sartorius). Additionally, 0.1% formic acid 
was added to both solvents to ensure that the mobile phase pH does not exceed 7. 
2.5.2 Sample Preparation 
Given the complexity of sample at hand and taking the dilution factor 
introduced by Nanoflow LC into consideration, LS 16 in-solution digests were 
concentrated from 12 mL to 50 µL using a speedvac. Due to the absence of guard 
column in Nanoflow LC setup, LS 16 peptides were cleaned and further concentrated 
using C18 ZipTips (Millipore) according to manufacturer’s instructions. Prior to 
Nanoflow LC separation, concentration of LS 16 peptides was estimated using 
Nanodrop. 
2.5.3 NanoFlow LC Run Conditions 
NanoFlow LC protocol is adopted from Kocher et al. (2012). Following an 
injection volume of 8 µL, NanoFlow LC system ran for 10 min with 2% solvent B. 
Peptides were then eluted at a stable flow rate of 275 nL/min with an increasing organic 
solvent of 2-45% solvent B for 1 hr. The gradient was followed by a 5 min steep 
increase to 90% solvent B, which was maintained for another 5 min. This step allows 
for column washing and was followed by an equilibration phase, by which the system 
returned to its original settings of 2% Solvent B. Detection wavelength and response 
time was set to 210 nm with 500 nm as a reference and 0.05 min, respectively.  
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Fractionation trigger mode was time-based; individual fraction duration was limited to 
3 min for a total volume of 0.8 µL/well. Throughout the NanoFlow LC run, the 
Autosampler Thermostat temperature was set to 4 ᵒC and the Thermostatted Column 
Compartment temperature was not controlled.  
The NanoFlow LC system was first optimized using a Trysin-digested BSA 
MS Standard (New England Biolabs, P8108S). Following optimization process, LS 16 
peptides were subjected to the same protocol as BSA-digest. Additionally, LS 16 
peptides were subjected to a 5 hrs NanoFlow LC separation by extension of linear 
gradient time. 
 
2.6 MALDI-TOF MS Analysis 
2.6.1 Plate Preparation 
Prior to MALDI-TOF MS analysis, samples were overlaid with CHCA matrix 
solution (10 mg of α-cyano-4-hydroxy-cinnamic acid in 50% ACN with 0.1% TFA) 
upon their spotting on a stainless steel target plate (Opti-TOF TM 384 Well Insert, 
123×81 mm RevA, Applied Biosystems, USA). Sample spots were air-dried before 
and after matrix addition.  In addition, 13 calibration spots were spotted on each 
stainless steel target plate. 
2.6.2 Calibration and Error Calculation  
All MALDI-TOF MS analysis were conducted on a 4800 MALDI TOF/TOF 
Analyzer instrument operated by the 4000 Series Explorer software version 3.5.1 
(Applied Biosystems, USA). Instrument calibration was achieved in reflector mode 
with the use of 4700 Proteomics Analyzer Calibration mixture (p/n: 4333604, Applied 
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Biosystems). Des-Arg-Bradykinin, Angiotensin, 1 Glu-Fibrinopeptide B, ACTH (clip 
1-17), ACTH (clip 18-39) and  ACTH (clip 7-38) constituted the 4700 Cal Mix peptide 
peaks with theoretical m/z values of  904.4681, 1,296.6853, 1,570.6774, 2,093.0867, 
2,465.1989 and 3,657.9294, respectively. Error calculation was preceded by the 
recording and averaging of 13 MALDI-TOF MS calibration spots readings. The values 
are recorded in Tables 2.2-2.9 as “Detected Mass of 13 cal. spots”. Errors in ppm were 
computed using the following formula (Tables 2.2-2.9): 
 
𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑚 𝑧⁄  – 𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙
𝑚
𝑧
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙
𝑚
𝑧
 × 106 
 Instrument was also calibrated in MS/MS mode using 4700 Cal Mix peptide 
peak at 1296.4681. The fragmentation pattern of peak 1296.4681 is listed in Table 
2.10. 
 
Table 2.2. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
JS 03, JS08, JS 10, JS 17 and JS 22. 
Standard  
Monoisotopic  
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.4027 72.3077 
Angiotensin I 1,296.6853 1,296.7717 66.6475 
Glu-Fibrinopeptide B 1,570.6774 1,571.0015 206.3157 
ACTH(clip1-17) 2,093.0867 2,092.7261 172.2756 
ACTH(clip18-39) 2,465.1989 2,465.3929 78.7098 
ACTH(clip 7-38) 3,657.9294 3,656.4228 411.8841 
Average Error   168.0234 
 
Table 2.3. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
JS 50, JS 52, JS 54, JS 56 and JS 60. 
Standard  
Monoisotopic  
mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.5708 113.5959 
Angiotensin I 1,296.6853 1,297.2807 459.1387 
Glu-Fibrinopeptide B 1,570.6774 1,571.7740 698.1402 
ACTH(clip1-17) 2,093.0867 2,094.2680 564.3862 
ACTH(clip18-39) 2,465.1989 2,467.2067 814.4623 
ACTH(clip 7-38) 3,657.9294 3,660.9397 822.9565 
Average Error   578.7800 
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Table 2.4. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
JS 61, JS 65 and JS 85. 
Standard  
Monoisotopic 
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.9730 558.2023 
Angiotensin I 1,296.6853 1,296.9701 219.6180 
Glu-Fibrinopeptide B 1,570.6774 1,570.8216 91.8065 
ACTH(clip1-17) 2,093.0867 2,092.5460 258.3126 
ACTH(clip18-39) 2,465.1989 2,464.3443 346.6676 
ACTH(clip 7-38) 3,657.9294 3,653.9397 1,090.6896 
Average Error   427.5494 
 
Table 2.5. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
LS 16, LS 24, LS 34, and LS 36. 
Standard  
Monoisotopic  
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.7987 365.5000 
Angiotensin I 1,296.6853 1,297.1851 385.4556 
Glu-Fibrinopeptide B 1,570.6774 1,570.5702 68.2337 
ACTH(clip1-17) 2,093.0867 2,093.7726 327.6849 
ACTH(clip18-39) 2,465.1989 2,467.2394 827.7332 
ACTH(clip 7-38) 3,657.9294 3,662.0363 1,122.7289 
Average Error   516.2227 
 
Table 2.6. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
LS 79, LS 89, LS 94, LS 98 and LS 103. 
Standard  
Monoisotopic  
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.5371 76.2616 
Angiotensin I 1,296.6853 1,296.6878 1.9001 
Glu-Fibrinopeptide B 1,570.6774 1,570.1998 304.0658 
ACTH(clip1-17) 2,093.0867 2,093.7460 314.9893 
ACTH(clip18-39) 2,465.1989 2,468.3850 1,292.4509 
ACTH(clip 7-38) 3,657.9294 3,661.3653 939.3042 
Average Error   456.8708 
 
Table 2.7. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for isolates: 
LS 57, LS 125 and LS 126. 
Standard  
Monoisotopic 
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.9841 570.4568 
Angiotensin I 1,296.6853 1,297.0376 271.7052 
Glu-Fibrinopeptide B 1,570.6774 1,570.1998 304.0658 
ACTH(clip1-17) 2,093.0867 2,093.7460 314.9893 
ACTH(clip18-39) 2,465.1989 2,467.2832 845.5061 
ACTH(clip 7-38) 3,657.9294 3,661.3653 939.3042 
Average Error   541.0045 
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Table2.8. 4700 Cal Mix standards used for MALDI TOF MS calibration in linear mode run for strains 
S. epidermidis and E. coli. 
Standard 
Monoisotopic  
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.2227 271.2797 
Angiotensin I 1,296.6853 1,296.4977 144.6487 
Glu-Fibrinopeptide B 1,570.6774 1,570.3512 207.6953 
ACTH(clip1-17) 2,093.0867 2,092.0023 518.0733 
ACTH(clip18-39) 2,465.1989 2,464.6131 237.6460 
ACTH(clip 7-38) 3,657.9294 3,656.5749 370.2931 
Average Error   291.6060 
 
Table2.9. 4700 Cal Mix standards used for MALDI TOF MS calibration in reflector mode run for LS 
16 peptide analysis. 
Standard 
Monoisotopic 
Mass (Da) 
Detected Mass of  
13 cal. spots (Da) 
Error (ppm) 
des-Arg-Bradykinin 904.4681 904.4648 3.6426 
Angiotensin I 1,296.6853 1,296.6942 6.8678 
Glu-Fibrinopeptide B 1,570.6774 1,570.6844 4.4993 
ACTH(clip1-17) 2,093.0867 2,093.0938 3.3778 
ACTH(clip18-39) 2,465.1989 2,465.2043 2.2083 
ACTH(clip 7-38) 3,657.9294 3,657.9345 1.3877 
Average Error   3.6639 
 
 
 
Table 2.10. Fragmentation pattern of 4700 Cal Mix peptide with mass of 1296.4681 obtained 
from 4000 Series Explorer software. 
 
Fragment Mass Fragment Ion Type 
110.072 H 
269.161 y2(+1) 
272.136 b2(+1) 
416.23 y3(+1) 
513.283 y4(+1) 
517.241 b4-17(+1) 
650.341 y5(+1) 
767.384 b6-17(+1) 
784.411 b6(+1) 
1,046.542 b8 + H2O(+1) 
1,165.591 b9(+1) 
1,181.658 y9(+1) 
1,183.601 b9 + H2O(+1) 
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2.6.3 Protein Analysis 
MALDI-TOF MS spectra were acquired in linear positive mode at a laser 
intensity of 5000 within a mass range of 800 to 12,000 Da. Focus mass was set to 6,000 
Da. Acceleration voltage was 20 kV, IS2 voltage was maintained at 19.3 kV, extraction 
delay time was 160 ns and laser frequency was set to 500 MHz. For each sample spot, 
one sum spectrum was accumulated from 1,000 measurements and minimum signal-
to-noise ratio was set to 20. Eleven replicate readings were recorded for every 
biological replicate. A total of 924 spectra were obtained in this study. Automated 
preprocessing (smoothing, baseline subtraction, and peak picking) was done using 
4000 Series Explorer Software version 3.5.3 (Applied Biosystems, USA). 
 
2.6.4 Shotgun proteomics - Peptides Analysis 
MALDI-TOF MS spectra were acquired in reflector positive mode at a laser 
intensity of 4600 within a mass range from 400 to 4,000 Da, with a focus mass of 1,200 
Da. Acceleration voltage was 20 kV, IS2 voltage was maintained at 16.1 kV, the 
extraction delay time was 300 ns, and laser frequency was set to 500 MHz. For each 
sample spot, one sum spectrum was accumulated from 800 measurements and 
minimum signal-to-noise ratio was set to 20.  
An interpretation method was utilized to collect MS/MS spectra in batch mode 
for Nanoflow LC fragments. This method allows for the dissociation of the strongest 
20 precursors/spot. An adduct exclusion list as well as peptides exclusion and inclusion 
lists is also supported in this method. An inclusion list was created for each of BSA-
digest and LS 16 digest based on a mass list extracted from MS Spectra in reflector 
mode. An exclusion list for CHCA matrix was also created in the same manner, in 
addition to an adduct exclusion for sodium and potassium at 21.982 and 37.956 m/z, 
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respectively. Inclusion and exclusion lists are found in the Appendix (Tables 7.1 and 
7.2). 
In addition to MALDI TOF MS/MS analysis of NanoFlow LC fragments, 
complete in-solution digest of LS 16 acquired in reflector mode in the ranges of 400-
1,000, 1,000-2,000, 2,000-3,000, 3,000-4,000 and 400-4,000 m/z were subjected to 
MS/MS analysis. 
MS/MS Spectra were acquired in a positive mode using CID by air (medium 
dissociation mode). For each sample spot, one sum spectrum was accumulated from 
500 measurements and minimum signal-to-noise ratio was set to 3.  
 
2.7 Bioinformatics  
2.7.1 Protein Analysis 
Subsequent statistical analysis of S. aureus proteomic profiles was performed 
using BioNumerics software version 7.1, developed by Applied Maths. The criteria for 
considering a protein peak present in an isolate was its occurrence in 6 out of 11 
MALDI replicates and 2 out of 3 biological replicate. Accordingly and taking 
experimental error (600 ppm) into consideration, one mass list was generated for every 
S. aureus isolate, S. epidermidis and E. coli strain. A dendrogram was created based 
upon a comparison of the S. epidermidis, E. coli strains’ and 25 S. aureus isolates’ 
peak lists. 
2.7.2 Peptides Analysis and Protein Identification 
Raw MS/MS spectra were searched against SwissProt and NCBInr databases 
using licensed MASCOT software, version 2.2.04. Other mammalia and other 
Firmicutes were chosen for BSA-digest and LS 16 taxonomy, respectively. A 
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maximum of 1 missed cleavage was permitted for tryptic digestion. 
Carbamidomethylation of cysteine residues and oxidation of methionine residues were 
set as fixed and variable modifications, respectively. MALDI TOF-TOF was chosen 
to be the instrument of this project, consequently the peptide charge was set to “1+”. 
As recommended by MASCOT, peptide and fragment tolerance was inferred using a 
standard, in this case, BSA digest. Accordingly, peptide and fragment tolerance were 
set to 0.6/0.2 and 0.1, respectively. Submitted data were in MGF and error tolerance 
was allowed. Unassigned protein sequences were blasted on non-redundant NCBI 
protein database with strict parameters; expect threshold was set to 10-5, gap cost of 7 
for existence and 2 for extension and database was limited to S. aureus proteins. 
Additionally, parameters were adjusted for short input sequences. The biological 
functions of identified proteins were obtained from NCBInr and UniProt databases. 
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Chapter Three 
 
 Results 
3.1 Protein Quantification 
Protein concentrations were measured for the 25 S. aureus isolates, S. 
epidermidis, E. coli strains and isolate LS 16. A total of 246 measurements were 
recorded for all isolates and strains, rising from 3 absorbance readings for each 
biological replicate and 3 biological replicates for each isolate/strain. Given the fact 
that a 96-well plate cannot accommodate this big number of samples plus the BSA 
standards, measurements were determined in 5 plates. Therefore 5 BCA-standard 
curves were plotted, one for each plate.  Figure 3.1 illustrates the BCA standard curve 
used in the measurement of protein concentrations of isolates LS 89, LS 98, LS 103, 
LS 125 and LS 126. BCA standard curves used in the measurements of protein 
concentrations of remaining isolates can be viewed in the Appendix (Figures 7.1-7.4) 
Figure 3.1. BCA standard curved from which protein concentrations of isolates LS 89, LS 94, LS 98, 
LS 103, LS 125 and LS 126 were extrapolated from.  
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Figure 3.2. Protein Concentrations in µg/mL for each of the 25 S. aureus isolates in this study. 
 
Concentrations of S. aureus protein extracts ranged from 184 to 1,708 µg/mL, 
with an average concentration of 793 µg/mL. Figure 3.2 illustrates the variation in 
protein concentrations of the 25 S. aureus isolates involved in this study. Additionally, 
the concentrations of protein extracts of S. epidermidis and E. coli strains were found 
to be 823 and 188 µg/mL, respectively. LS 16, the S. aureus isolate chosen for further 
MS analysis in the process of protein identification, had an average protein 
concentration of 427 µg/mL. 
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3.2. Proteomic Fingerprinting 
MALDI-TOF MS analysis verified that every isolate has a unique proteomic 
fingerprint. Figures 3.3 to 3.9 represent MALDI-TOF MS spectra (linear mode with 
mass range 800-1,200 m/z) for formic acid protein extracts of JS isolates, LS isolates, 
S. epidermidis and E. coli strains.  
 
 
Figure 3.3. MALDI-TOF MS spectra for formic acid protein extracts of isolates JS 03 (top), JS 08 
(middle) and JS 10 (bottom).  
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Figure 3.4.  MALDI-TOF MS spectra for formic acid protein extracts of isolates JS 17 (top), JS 22 
(middle-top), JS 50 (middle-bottom) and JS 52 (bottom). 
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Figure 3.5.  MALDI-TOF MS spectra for formic acid protein extracts of isolates JS 54 (top), JS 56 
(middle-top), JS 60 (middle-bottom) and JS 61 (bottom). 
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Figure 3.6.  MALDI-TOF MS spectra for formic acid protein extracts of isolates JS 65 (top), JS 85 
(middle-top), LS 16 (middle-bottom) and LS 24 (bottom). 
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Figure 3.7.  MALDI-TOF MS spectra for formic acid protein extracts of isolates LS 34 (top), LS 36 
(middle-top), LS 57 (middle-bottom) and LS 79 (bottom). 
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Figure 3.8.  MALDI-TOF MS spectra for formic acid protein extracts of isolates LS 89 (top), LS 94 
(middle-top), LS 98 (middle-bottom) and LS 103 (bottom). 
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Figure 3.9. MALDI-TOF MS spectra for formic acid protein extracts of isolates LS 125 (top), LS 126 
(middle-top), S. epidermidis strain (middle-bottom) and E. coli strain (bottom). 
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3.3. Peak analysis 
Upon data analysis, not a single peak was found common between all S. aureus 
isolates. Protein peaks, which fall shortly outside the considered error of 600 ppm in 
this study, were averaged for protein peaks that are considered discriminatory for S. 
aureus by Abdallah (2011) and Wolters et al. These protein peaks appear to be the 
highest-occurring protein peaks and are listed in Table 3.1.  
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Table 3.1. The frequency of the highest-occurring protein peaks detected by MALDI-TOF MS in linear mode of formic acid protein extracts of S. aureus isolates. 
 
Average masses of protein peaks that are assumed to be isomers of the same protein. 
Peak Mass 
(Da)
JS 03 JS 08 JS 10 JS 17 JS 22 JS 50 JS 52 JS 54 JS 56 JS 60 JS 61 JS 65 JS 85 LS 16 LS 24 LS 34 LS 36 LS 57 LS 79 LS 89 LS 94 LS 98 LS 103 LS 125 LS 126 Peak Count
% 
Occurrence
4813.17 x x x x 4 16%
4819.16 x x x x 4 16%
4825.1 x x x 3 12%
4829.33 x x x x x 5 20%
4833.67 x x x 3 12%
4824.09 19 76%
6411.1 x x x x x x x x x 9 36%
6424.73 x x x x x x x x 8 32%
6436.12 x x x x x 5 20%
6423.98 22 88%
6586.29 x x x x x x 6 24%
6600.09 x x x x x x x 7 28%
6613.29 x x x x 4 16%
6635.59 x x 2 8%
6608.81 19 76%
8903.83 x x x 3 12%
8923.55 x x x x 4 16%
8875.75 x x x x 4 16%
8887.78 x x 2 8%
8897.73 13 52%
9621.97 x x x x x x x x x x 10 40%
9645.88 x x x x x x x x 8 32%
9666.97 x x x x x 5 20%
9644.94 23 92%
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3.4. Correlating Proteomic Fingerprints and Genotypic 
Characteristics 
To correlate proteomic data generated by MALDI-TO MS to genotypic typing 
characteristics (MLST-cc, spa-cc, mecA types, PVL and site of location), MALDI-
TOF MS raw data acquired for formic acid protein extracts of S. aureus isolates, S. 
epidermidis and E. coli strains were compared using BioNumerics software and a 
dendrogram was generated, Figure 3.10. The dendrogram was based on similarities of 
protein masses among different isolates. Genotypic characteristics are listed on the 
right of the dendrogram. While no relationship was spotted between proteomic 
fingerprints and genotypic characteristics, a geographic separation of isolates was 
apparent in the dendrogram. S. epidermidis and E. coli strains were not clustered 
separately in the dendrogram, hence Cluster Analysis based on peak similarity is not 
enough to differentiate between S. aureus isolates and S. epidermidis and E. coli 
strains. 
Figure 3.10. Dendrogram representation of hierarchical cluster analysis of S. aureus isolates (LS# and 
JS#), S. epidermidis (SE) and E. coli (EC) strains along with their corresponding genotypic 
characteristics.  
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3.5. NanoFlow LC MS/MS Optimization 
MALDI-TOF MS spectrum (reflector mode) of trypsin-digested BSA standard 
prior to Nanoflow LC separation is shown in Figure 3.11. The spectrum allows the 
visualization of the most prominent peaks of trypsin-digested BSA standard. 
Figure 3.11. MALDI-TOF MS spectrum acquired in reflector mode (mass range: 400-4000 m/z) for 
Trysin-digested BSA MS Standard. 
 
Trysin-digested BSA standard was used in the process of optimizing Nanoflow 
LC MS/MS; the resulting chromatogram is shown in Figure 3.12. Peptides 
fractionation was optimized by visualizing peptides in MALDI-TOF MS reflector 
mode-generated raw data. Only prominent peaks in MALDI-TOF MS spectrum of 
trypsin digested standard (Figure 3.11) appear in MALDI-TOF MS spectra of 
fractionated trypsin-digested BSA standard. Peptide fractionation profile can be 
viewed in the Appendix (Table 7.3). 
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Figure 3.12. Nanoflow LC chromatogram of trypsin-digested BSA standard. Injection volume: 8 µL. 
Linear gradient of 2-45% solvent B. Detection wavelength: 210nm. Time-based fractionation: 3min. 
 
MS/MS spectrum for the peptide with mass of 1,480.07 m/z from trypsin-
digested BSA standard is shown in Figure 3.13. MS/MS ion search of trypsin-digested 
BSA standard was successfully performed using MASCOT, following one hour 
Nanoflow separation coupled with MALDI-TOF MS/MS analysis for the 20 highest 
peaks per well (Figure 3.14).  
Figure 3.13. MALDI-TOF MS/MS spectrum for peptide with m/z value of 1,480.07 from Trysin-
digested BSA Standard. 
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Figure 3.14. MASCOT score histogram showing the result of MS/MS ion search in SwissProt database 
for Trysin-digested BSA MS Standard after fractionation by NanoFlow LC. Individual ions scores > 37 
indicate identity or extensive homology (p<0.05). Protein scores are the sum of individual ion scores. 
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3.6. Identification of S. aureus Proteins 
A trypsin-digested LS 16 protein sample was analyzed by MALDI-TOF MS 
prior to Nanoflow LC separation. Spectra of trypsin-digested LS 16 peptides acquired 
in reflector mode in the ranges of 400-4,000, 400-1,000, 1,000-2,000 and 2,000-3,000 
m/z are illustrated in Figures 3.15 and 3.16, respectively. The spectra allow the 
visualization of the most prominent peaks of trypsin-digested LS 16 peptides in 
different mass windows. MALDI-TOF MS/MS analysis of the spectra mentioned was 
performed and followed by MASCOT database search. 
 
Figure 3.15. MALDI-TOF MS spectra acquired in reflector mode for trypsin-digested LS 16 peptides 
in a mass range of 400-4,000 m/z (top) and 400-1,000 m/z (bottom). 
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Figure 3.16. MALDI-TOF MS spectra acquired in reflector mode for trypsin-digested LS 16 peptides 
in a mass range of 1,000-2,000 m/z (top) and 2,000-3,000 m/z (bottom). 
 
 
Figure 3.17. Nanodrop Plot from which LS 16 peptides concentration was estimated to nearly 
90 mg/mL. 1 mm Absorbance = 1 mg/ mL. 
 
Following speedvac concentration and ZipTip clean-up, LS 16 peptides 
concentration was estimated to be 90 mg/mL using Nanodrop (Figure3.17). Protein 
identification for S. aureus was performed in the same manner as Trysin-digested BSA 
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MS standard. Accordingly, an hour NanoFlow LC separation method was set up to 
separate LS 16 peptides over a gradient of 2-45 % Solvent B (Figure 3.18).  
 
Figure 3.18. Nanoflow LC chromatogram of trypsin-digested LS 16. Injection volume: 8 µL. Linear 
gradient of 2-45% solvent B. Detection wavelength: 210nm. Time-based fractionation: 3min.  
 
MS/MS spectrum for the peptide with mass of 1,378.72 m/z from trypsin-
digested and Nanoflow LC fractionated LS 16 is shown in Figure 3.19. MS/MS ion 
search of trypsin-digested LS 16 peptides was successfully performed using 
MASCOT, following Nanoflow LC separation coupled with MALDI-TOF MS/MS 
analysis for the 20 highest peaks per well/fraction. Figures 3.20 and 3.21 illustrates 
successful protein identification by MASCOT for SwissProt and NCBInr databases, 
respectively. 
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Figure 3.19. MALDI-TOF MS/MS spectrum for peptide with m/z value of 1,378.72 from Trysin-
digested LS 16 protein extract. 
 
 
Figure 3.20. MASCOT score histogram showing the result of MS/MS ion search in SwissProt database 
for Trysin-digested LS 16 protein extract after fractionation by NanoFlow LC. Individual ions scores > 
31 indicate identity or extensive homology (p<0.05). Protein scores are the sum of individual ion scores. 
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Figure 3.21. MASCOT score histogram showing the result of MS/MS ion search in NCBInr database 
for Trysin-digested LS 16 protein extract after fractionation by NanoFlow LC. Individual ions scores > 
50 indicate identity or extensive homology (p<0.05). Protein scores are the sum of individual ion scores. 
 
 
Proteins identified in this study for isolate LS 16 are listed in Tables 3.2. 
Proteins numbered 1-22 in Tables 3.2 are identified from MS/MS spectra of one hour 
Nanoflow LC fractions. Protein numbered 23 in Table 3.2 is identified from MS/MS 
spectra of five hour Nanoflow LC fractions. Proteins numbered 24-32 in Table 3.2 are 
identified from MS/MS spectra of complete and unfractioned in-solution tryptic-digest 
of LS 16 collected in reflector mode with mass range of 400-1,000 m/z. Proteins 
numbered 32-36 in Table 3.2 are identified from MS/MS spectra of complete and 
40 
 
unfractioned in-solution tryptic-digest of LS 16 collected in dissected reflector mode 
of mass ranges of 400-1,000, 1,000-2,000, 2,000-3,000 and 3,000-4,000 m/z.  
Proteins identified to species other than S. aureus were blasted on non-
redundant (nr) NCBI S. aureus database. Resulting S. aureus homologues are listed in 
Table 3.3. S. aureus homologues were not found for 2 identified proteins with 
molecular weight of 25,571 and 40,960 Da. Table 3.4 lists protein blast results of 
MASCOT unassigned peptides in non-redundant (nr) NCBI S. aureus database. 
Highest scoring protein is reported for blastp searches. Tables 3.5 and 3.6 list functions 
of 59 identified proteins. Identified proteins that were not assigned a molecular weight 
and a function are listed in Table 7.5 in the Appendix. 
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Table 3.2. Proteins identified from trysin-digested LS 16 formic acid extract by MASCOT search 
engine. 
 
 
No. Database MW (Da) ID Protein Species
1 9620 DBH_STAAC DNA-binding protein HU Staphylococcus aureus
2 13348 Y1117_STAHJ UPF0342 protein SH1117 Staphylococcus haemolyticus
3 9651 DBH1_BACHD DNA-binding protein HU-1 Bacillus halodurans
4 29580 Y235_STAEQ UPF0447 protein SERP0235 Staphylococcus epidermidis
5 28960 Y3362_GEOTN UPF0447 protein GTNG_3362 Geobacillus thermodenitrificans
6 88841 PBPA_CLOAB Penicillin-binding protein 1A Clostridium acetobutylicum
7 107792 SYI_HALOH Isoleucine--tRNA ligase Halothermothrix orenii
8 40023 GCST_GEOKA Aminomethyltransferase Geobacillus kaustophilus
9 9619 gi|488404375 transcriptional regulator Staphylococcus epidermidis
10 9646 gi|446966605 transcriptional regulator Staphylococcus aureus
11 9650 gi|488380409 transcriptional regulator Staphylococcus
12 13302 gi|15924835 hypothetical protein SAV1845 Staphylococcus aureus
13 12256  gi|532359921 hypothetical protein SAAG_01746 Staphylococcus aureus
14 13332 gi|446212447 hypothetical protein Staphylococcus aureus
15 13287 gi|379796200 hypothetical protein SAMSHR1132_16910 Staphylococcus aureus
16 9805 gi|90962747 DNA-binding protein HU Lactobacillus salivarius
17 9678 gi|497173090 DNA-binding protein HU Weissella ceti
18 14040 gi|222151808 hypothetical protein MCCL_1563 Macrococcus caseolyticus
19 25571 gi|553957006 hypothetical protein Eubacterium brachy
20 9617 gi|319892463 DNA-binding protein HBsu Staphylococcus pseudintermedius
21 9604 gi|446966606 transcriptional regulator Staphylococcus aureus
22 9634 gi|488364546 transcriptional regulator Staphylococcus
23 44043 TGT_BACLD Queuine tRNA-ribosyltransferase Bacillus licheniformis
24 43882 BRPA_STRMU Biofilm regulatory protein A Streptococcus mutans serotype c
25 8085 RL29_STAA2 50S ribosomal protein L29 Staphylococcus aureus
26 10279 Y1445_STAAN UPF0297 protein Staphylococcus aureus
27 11029 ESXA_STAAC Virulence factor EsxA Staphylococcus aureus
28 10229 RS16_STAA1 30S ribosomal protein S16 Staphylococcus aureus
29 14607 RS9_STAA1 30S ribosomal protein S9 Staphylococcus aureus
30 31122 gi|557828691 2-dehydropantoate 2-reductase Exiguobacterium sp. MH3
31 11271 SP5G_STAA2 Putative septation protein SpoVG Staphylococcus aureus
32 13150 gi|492418262 Fic family protein Eubacterium saphenum
33 40960 gi|495696491 hydrogenase expression/formation protein HypD Clostridium sp. Maddingley MBC34-26
34 28880 gi|493632938 DNA repair protein RecO Lactobacillus jensenii
35 34894 HPRK_CLOPE HPr kinase/phosphorylase Clostridium perfringens
36 7770 Y1696_STAAN UPF0435 protein Staphylococcus aureus
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Table 3.3. Proteins identified to species other than S. aureus and their corresponding S. aureus homologues. Homologues are obtained from non-redundant (nr) NCBI S. 
aureus database blast search. 
No.
Database 
MW (Da)
ID Protein Species S. aureus Homologue ID Homologue Protein
1 13348 Y1117_STAHJ UPF0342 protein SH1117 Staphylococcus haemolyticus Y1663_STAAN UPF0342 protein SA1663
2 9651 DBH1_BACHD DNA-binding protein HU-1 Bacillus halodurans gi|580255613 DNA-binding protein HU
3 29580 Y235_STAEQ UPF0447 protein SERP0235 Staphylococcus epidermidis Y537_STAAB UPF0447 protein SAB0537c
4 28960 Y3362_GEOTN UPF0447 protein GTNG_3362 Geobacillus thermodenitrificans gi|379795059 hypothetical protein SAMSHR1132_05310 
5 88841 PBPA_CLOAB Penicillin-binding protein 1A Clostridium acetobutylicum gi|49483639 penicillin-binding protein 2
6 107792 SYI_HALOH Isoleucine--tRNA ligase Halothermothrix orenii gi|446306826 isoleucyl-tRNA synthetase
7 40023 GCST_GEOKA Aminomethyltransferase Geobacillus kaustophilus  gi|446015501 glycine cleavage system protein T
8 9619 gi|488404375 transcriptional regulator Staphylococcus epidermidis gi|15924463 DNA-binding protein II
9 9805 gi|90962747 DNA-binding protein HU Lactobacillus salivarius gi|580255613 DNA-binding protein HU
10 9678 gi|497173090 DNA-binding protein HU Weissella ceti gi|580255613 DNA-binding protein HU
11 14040 gi|222151808 hypothetical protein MCCL_1563 Macrococcus caseolyticus gi|446212447 hypothetical protein
12 25571 gi|553957006 hypothetical protein Eubacterium brachy No Homologue found
13 9617 gi|319892463 DNA-binding protein HBsu Staphylococcus pseudintermedius gi|446966605 transcriptional regulator
14 44043 TGT_BACLD Queuine tRNA-ribosyltransferase Bacillus licheniformis gi|579740496 queuine tRNA-ribosyltransferase
15 43882 BRPA_STRMU Biofilm regulatory protein A Streptococcus mutans serotype c gi|82751903 transcriptional regulator
16 31122 gi|557828691 2-dehydropantoate 2-reductase Exiguobacterium sp. MH3 gi|379796910 putative ketopantoate reductase
17 13150 gi|492418262 Fic family protein Eubacterium saphenum gi|507417608 PfkB family carbohydrate kinase
18 40960 gi|495696491 hydrogenase expression/formation protein HypD Clostridium sp. Maddingley MBC34-26 No Homologue found
19 28880 gi|493632938 DNA repair protein RecO Lactobacillus jensenii gi|514066500 DNA repair protein RecO
20 34894 HPRK_CLOPE HPr kinase/phosphorylase Clostridium perfringens gi|486396223 HPr kinase/phosphorylase
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Table 3.4. Proteins identified by non-redundant (nr) NCBI S. aureus database search for MASCOT 
unassigned peptide sequences. 
  
No.
Observed             
Mass (m/z)
 Peptide Sequence ID Protein
1 1729.8831   IEDIDVFEATAIQK + [+138.1045 at C-term K] gi|579935718 acetyl-CoA acetyltransferase, partial
2 1378.7352   SPEITFGMLEVR  gi|583105701 methionine sulfoxide reductase B, partial
3 841.5296   VSPGQLIK gi|379796404 sensor kinase protein
4 1881.8877   QIAANAGLEGSVIVERVR gi|577289267 chaperonin, partial
5 1414.7722   IRAALPTLQYLR gi|580848717 oxidoreductase
6 1307.6460   YLSAVNGLLETK gi|584847631 hypothetical protein U620_02608
7 1480.8762   IVLTGHSLTIAEAR gi|580689402 PTS system, ascorbate-specific IIC
8 1601.7997   IDRLSMTLMNTMK + 3 Oxidation (M) gi|580965588 coenzyme A disulfide reductase, partia
9 1911.0636   HSQATDVLIMLISIQNK gi|447003213 membrane protein
10 1917.9103   LLGFAIHQEMDNSRMR gi|581796105 protein translocase subunit secA 2
11 2063.9983   DLNAADIEAAMRMIEGTAR + Oxidation (M) gi|584655548 50S ribosomal protein L11
12 2104.0530   IMDINGLDKISTEVVETAR gi|487738499 putative ATP-binding domain protein, partial
13 1464.7075   LNAKSVEDAFNTR gi|580927722 hypothetical protein U042_02830
14 954.4770   NILVLGLGR gi|487722202 amino acid ABC transporter substrate-binding protein
15 1679.8086   IQNGASPEDFAVLYR gi|582606875 hypothetical protein U343_02428, partial
16 1730.9032   VGMHCAVASPKGYEPK gi|446045965 acetyl-CoA synthetase
17 1918.8976   NDIMLTQQTAISRQQR + Oxidation (M) gi|386729591 Sodium/proline symporter
18 1361.6914   VTTLMGDKVEPR + Oxidation (M) gi|582616066 DNA topoisomerase 4 subunit B, partial
19 1935.8772   TAHGSWADSQMEPPEHR gi|487730301 membrane protein
20 1036.5518   FGVDTRSVR gi|582450771 hypothetical protein U271_01845
21 852.4320   LNAYPFK gi|487730899 30S ribosomal protein S2
22 1736.8127   LDEMEQDGTFDVLPK gi|582657440 DNA topoisomerase 3, partial
23 928.5194   ILEAPEEK gi|17227188 hypothetical protein pETB_p11
24 1306.6812   LADMVTPEMRK + Oxidation (M) gi|580256465 50S ribosomal protein L17
25 553.3952   GGYTR gi|487368615 peptide methionine sulfoxide reductase msrB
26 2225.1006   EEGLYVDIVSGKPLFTSKDK gi|514309011 chloramphenicol/florfenicol resistance protein, partial
27 2698.2009   LMPIGNKYSIEEILDACDYYFK + Oxidation (M) gi|578670717 PTS system EIIBC component, partial 
28 1008.5385   VVGPGTLIPR gi|581372899 30S ribosomal protein S11, partial 
29 1882.9065   VAGGKHSFIEHEEDISK gi|581372899 30S ribosomal protein S11, partial
30 1400.7163   EVFVPIEQGKVR gi|579648211 cysteinyl-tRNA synthetase, partial
31 934.4845   EKAAFIQK gi|510813435 hypothetical protein
32 1735.8058   KTVGILTEMQAEEDR + Oxidation (M) gi|487721653 GTP diphosphokinase
33 920.4692   DVDSDTLR gi|487754004 hypothetical protein
34 1934.8690   FMFADAVQCDFDKQGR gi|521212208 cell division protein MraZ
35 1957.9141   GWEAAVSAIEMANVLRGLA gi|580654011 6,7-dimethyl-8-ribityllumazine synthase
36 2274.0833   AGLTEIMVAMNYLVHNPQIK + 2 Oxidation (M) gi|379795214 peptidase T
37 2059.9998   EVEEHLLHVAKADPWMR gi|487741723 DNA polymerase III subunit alpha
38 1740.8979   LDELPGGALVGTSSLRR gi|447152960 hypothetical protein, partial
39 1463.7273   GSFLSNISKNLQR gi|580840478 hypothetical protein T991_02716
40 1956.8464   IAESRTYPQFIPYTDR gi|447004115 hypothetical protein
41 912.4804   IYNAYLR gi|582796996 hypothetical protein U433_02585
42 1900.9148   ASMALNMDIATNSKFDR + Oxidation (M) gi|580175801 aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
43 2064.9751   ESTIGIDAGGTLTKIAYLNK gi|446612392 pantothenate kinase
44 1381.6901   AGINMDGINFSAR + Oxidation (M) gi|584237569 cation:proton antiporter
45 1678.8104   EEQDSEMLEVKTPK + Oxidation (M) gi|446056903 GTPase Era
46 1912.0410   GMWAMPDLMAEMLKQK + 2 Oxidation (M) gi|487739866 TelA
47 2282.1580   AMETVGVKPLIKPIRGGTDGSR gi|487709438 peptidase T
48 2058.9949   IIEQIGTYNPTSANAPEIK gi|15924228 30S ribosomal protein S16
49 977.6641   TGGHFIAMK + Oxidation (M) gi|584237570 cation:proton antiporter
50 2331.1619   HVLLSHHGKGEWGSPKPPLVR gi|470191645 Cmp-binding-factor=1
51 531.4152   VPSTK gi|580754041 transposase for insertion sequence-like element IS431mec
52 2275.0618   IPLILEVTSNQYESHTQFR gi|379795714 Nuclease sbcCD subunit C
53 2040.9270   TPAANKMDIFEDGSIVGLF + Oxidation (M)  gi|446923043 serine protease
54 1974.8595   LDGKELPPVEMMQTLNK + 2 Oxidation (M) gi|379796531 DJ-1/PfpI family protein
55 1975.8680   LIEMGAEVEENGDSVLVR + Oxidation (M) gi|584763348 kinase-associated protein B
56 2103.0493   VGGLFSKEIQEAGNVVISQK gi|10956153 recombination protein
57 2090.9849   ISGDEALEIISKIFRPFR gi|446986725 UDP-N-acetyl-D-galactosamine dehydrogenase
58 1023.7339   ISYPESSLK gi|379796521| tagatose-6-phosphate kinase
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Table 3.5. Functions and Molecular weights of 59 identified proteins, obtained from Uniprot or NCBInr databases. 
  
No. ID Protein Molecular Weight (Da) Database Function
1 gi|379796404 sensor kinase protein 101,506 uniprot membrane protein involved in kinase transferase
2 gi|447003213 membrane protein 15,526 uniprot membrane protein with uncharacterized function
3 gi|487738499 putative ATP-binding domain protein, partial 5,026 uniprot ATP-binding protein 
4 gi|487722202 amino acid ABC transporter substrate-binding protein 9174 NCBI (protein) Protein involved in amino acid transport and metabolism and Signal transduction mechanisms
5 gi|446045965 acetyl-CoA synthetase 12255 NCBI (protein) Acetyl-CoA synthetase containing an Adenylate forming domain and a CoA binding site 
6 gi|386729591 Sodium/proline symporter 56,409 uniprot Transmembrane  i0n sodium ion transporter protein
7 gi|487730301 membrane protein 12,465 uniprot Membrane protein with uncharacterized function
8 gi|487730899 30S ribosomal protein S2 15128 NCBI (protein) Ribosomal protein involved in translation
9 gi|17227188 hypothetical protein pETB_p11 5,864 uniprot Uncharacterized protein
10 gi|487368615 peptide methionine sulfoxide reductase msrB 16,226 uniprot Repair protein with peptide-methionine (R)-S-oxide reductase activity that functions in response to oxidative stress
11 gi|514309011 chloramphenicol/florfenicol resistance protein, partial 25,395 uniprot Cytoplasm protein involved in methylation and rRna methylation
12 gi|510813435 hypothetical protein 4061 NCBI (protein) Uncharacterized protein
13 gi|487754004 hypothetical protein 40,205 uniprot Guanosine tetraphosphate that belongs to relA/spoT family. A mediator of the stringent response that coordinates a variety of cellular activities in response to changes in nutritional abundance 
14 gi|521212208 cell division protein MraZ 16,959 uniprot Cell cycle protein involved in cell division
15 gi|379795214 peptidase T 45,930 uniprot Cytoplasm proteolytic enzyme that Cleaves the N-terminal amino acid of tripeptides
16 gi|487741723 DNA polymerase III subunit alpha 89,622 uniprot Protein with  3'-5' exonuclease activity that functions in DNA replication
17 gi|447152960 hypothetical protein, partial 15331 NCBI (protein) An intermediate enzyme in the biosynthetic pathway of tetrapyrrolic ring systems, such as heme, chlorophylls, and vitamin B12
18 gi|447004115 hypothetical protein 16,235 uniprot Uncharacterized function
19 gi|446612392 pantothenate kinase 29,165 uniprot Cytoplasm kinase involved in Coenzyme A biosynthesis
20 gi|446056903 GTPase Era 34,330 uniprot Essential GTPase that binds GDP and GTP, with rapid nucleotide exchange. Plays a role in 16S rRNA processing and 30S ribosomal subunit biogenesis and possibly in cell cycle regulation and energy metabolism
21 gi|487739866 TelA 22302 uniprot Toxic anion resistance protein (TelA)
22 gi|487709438 peptidase T 8,674 uniprot Protein with hydrolase activity
23 gi|15924228 30S ribosomal protein S16 10,235 uniprot Ribosomal protein involved in translation
24 gi|470191645 Cmp-binding-factor=1 33,711 uniprot Metal-ion binding protein with phosphoric diester hydrolase activity
25 gi|379795714 Nuclease sbcCD subunit C 117,130 uniprot DNA repair protein with nuclease activity
26  gi|446923043 serine protease 84,510 uniprot Serine-type endopeptidase activity
27 gi|379796531 DJ-1/PfpI family protein 23445 NCBI (protein) Type 1 glutamine amidotransferase with (GATase1)-like domain
28 gi|10956153 recombination protein 48,496 uniprot DNA binding protein
29 gi|446986725 UDP-N-acetyl-D-galactosamine dehydrogenase 48014 NCBI (protein) Outer membrane protein that belongs to the UDP-glucose/GDP-mannose dehydrogenase family with possible function in cell envelope biogenesis
30  gi|379796521 tagatose-6-phosphate kinase 33,950 uniprot ATP-binding protein involved in lactose metabolism
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No. ID Protein Molecular Weight (Da) Database Function
31 Y1663_STAAN UPF0342 protein SA1663 13,310 uniprot Uncharacterized function
32 Y537_STAAB UPF0447 protein SAB0537c 29,328 uniprot Uncharacterized function
33 gi|379795059 hypothetical protein SAMSHR1132_05310 29,252 uniprot Uncharacterized function
34 gi|49483639 penicillin-binding protein 2 79,295 uniprot Membrane protein that binds penicillin
35 gi|446306826 isoleucyl-tRNA synthetase 104,843 uniprot Cytoplasm protein involved in protein synthesis by Catalyzing the attachment of isoleucine to tRNA
36 gi|15924463 DNA-binding protein II 9,626 uniprot DNA-binding protein involved in chromosome condensation 
37 gi|580255613 DNA-binding protein HU 40,504 uniprot Cytoplasm protein with aminomethyltransferase activity leading to glycine degradation
38 gi|446212447 hypothetical protein 13,340 uniprot Uncharacterized function
39 gi|446966605 transcriptional regulator 9,652 uniprot DNA-binding protein involved in chromosome condensation 
40 gi|82751903 transcriptional regulator 34,768 uniprot Protein involved in transcription regulation
41 gi|379796910 putative ketopantoate reductase 32,451 uniprot Cytoplasm protein that binds NADP and is involved in pantothenate biosynthetic process
42 gi|514066500 DNA repair protein RecO 28,207 uniprot Protein involved in DNA repair and RecF pathway recombination
43 gi|486396223 HPr kinase/phosphorylase 6022 NCBI (protein) Kinase protein with specific and non-specific DNA binding sites. Helix-turn-helix XRE-family like protein
44 DBH_STAAC DNA-binding protein HU 9620 uniprot Histone-like DNA-binding protein which is capable of wrapping DNA to stabilize it, and thus prevents its denaturation under extreme environmental conditions
45 gi|446966605 transcriptional regulator 9646 uniprot DNA-binding protein involved in chromosome condensation 
46 gi|488380409 transcriptional regulator 9650 uniprot DNA-binding protein involved in chromosome condensation 
47 gi|15924835 hypothetical protein SAV1845 13302 uniprot Uncharacterized function
48  gi|532359921 hypothetical protein SAAG_01746 12256 uniprot Uncharacterized function
49 gi|446212447 hypothetical protein 13332 uniprot Uncharacterized function
50 gi|379796200 hypothetical protein SAMSHR1132_16910 13287 uniprot Uncharacterized function
51 gi|446966606 transcriptional regulator 9604 uniprot DNA-binding protein involved in chromosome condensation 
52 gi|488364546 transcriptional regulator 9634 uniprot Non-specific DNA-binding protein HBsu signal recognition particle-like (SRP) component
53 RL29_STAA2 50S ribosomal protein L29 8085 uniprot Ribosomal protein involved in translation
54 Y1445_STAAN UPF0297 protein 10279 uniprot Uncharacterized function
55 ESXA_STAAC Virulence factor EsxA 11029 uniprot Secreted virulence factor involved in pathogenesis by interacting with EsxB. Involved in abscess formation
56 RS16_STAA1 30S ribosomal protein S16 10229 uniprot Ribosomal protein involved in translation
57 RS9_STAA1 30S ribosomal protein S9 14607 uniprot Ribosomal protein involved in translation
58 SP5G_STAA2 Putative septation protein SpoVG 11271 uniprot Protein with possible function in septation
59 Y1696_STAAN UPF0435 protein 7770 uniprot Uncharacterized function
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Chapter Four 
 
Discussion 
 
MALDI-TOF MS analysis of bacterial isolates is renowned as an efficient 
identification method in clinical laboratories (Gagnaire et al., 2012). On the other hand, 
culture conditions and sample preparation methods introduce many variables to the 
identification process. Those variables affecting spectrum quality and reproducibility 
of S. aureus profiling were first thoroughly studied by Goldstein et al. in August 2013. 
Cultures grown in broth and processed following protein extraction method appears to 
offer most promising results for S. aureus characterization (Goldstein, Zhang, Borror, 
Rago, & Sandrin, 2013). 
Protein concentration introduces an additional variable to MALDI-TOF MS 
analysis; concentrations of the 25 S. aureus protein extracts were measured to 
determine the effect of protein concentration on proteomic analysis. Protein 
concentrations of different isolates range 10 folds; variation of the protein 
concentration was not corrected for in this study. It was also observed that protein 
concentrations of the same isolate differ drastically among biological replicates. The 
concentration of the one biological replicate was almost 4 times higher than another 
biological replicate for the case of isolate LS 34. A major difficulty lies in adjusting 
this variation, given that it will lead to dilution of protein extracts. One solution to this 
challenge lies in adjusting cell density prior to protein extraction method (Sitepu et al., 
2012).  
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In a previous study in our lab, El Hage (2012) showed the absence of 
correlation between protein concentrations of S. aureus formic acid extracts and 
protein peak counts in MALDI-TOF MS spectra (linear mode). This result was 
confirmed in this study, whereby protein extract concentration of isolate LS 34 was 
184 µg/mL and the protein peak count 34, whereas extracts of isolate JS 17 had a 
protein concentration of 878 µg/mL and a protein peak count of 9. 
 
4.1 Assessment of Proteomic Profiles 
MALDI-TOF MS spectra, acquired in linear mode with a mass range of 800-
12,000 m/z for formic acid protein extracts of 25 S. aureus isolates, S. epidermidis 
isolate and E. coli isolate, demonstrates a unique fingerprint for every isolate based on 
visual inspection of Figures 3.3-3.9 and spectral analysis using BioNumerics software. 
It must be noted that isolates are expected to exhibit differential growth rates, 
accordingly extracting proteins at the same time (22-24 hrs) for all isolates introduces 
a variation in the type and quantity of the extracted proteins. In this study, growth 
curves were not prepared for S. aureus isolates as to mimic the identification process 
in clinical settings. 
Upon comparison of MALDI-TOF MS spectra of 25 S. aureus isolates, S. 
epidermidis isolate and E. coli isolate, a cluster analysis, based on Jeffrey’s X 
similarity coefficient was generated. Our cluster analysis reveals geographic separation 
of S. aureus isolates, e.g. into isolates originating from the Lebanese vs. Jodanian 
hospital. No relationship between proteomic fingerprints and spa-cc, MLST-cc, mecA, 
PVL or site of location was detected.  Furthermore, clustering was not species-
dependent; S. epidermidis and E. coli were not clustered separately in the dendrogram. 
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Previously, MALDI-typing was achieved to the species-level, yet a large database of 
spectra, e.g. Bruker Biotyper was implemented in the process. 
Although identification of S. aureus to the species level based on MALDI-TOF 
MS spectra in mass range of 800-12,000 m/z is applied in clinical laboratories, protein 
signatures in this range were not evaluated until January 2013 by Josten et al. 
Asymmetry of spectra among isolates can be owed to peak intensity variation, peak 
loss and peak shift. While the former two conditions can be directly correlated with 
culture conditions, the latter can also be an indication of a gene mutation of the detected 
peptides. Altered gene product results in molecular weight difference due to an amino 
acid exchange leading to peak shifts (Josten et al., 2013).  
Considering an experimental error of 600 ppm, any amino acid exchange 
occurring in a specific protein of one of the isolates will cause a peak shift, hence the 
protein becomes easily mistakable as a different protein. For example, if a protein with 
a mass of 6,000 m/z undergoes an amino acid exchange of glycine with tryptophan, its 
mass becomes 6,129 m/z. A mass shift of 129 Da exceeds the observed error range of 
± 3.6 Da at 6,000 m/z in this study, hence the protein at 6,129 m/z would be falsely 
reported as a different protein. Upon data analysis considering a low error range of 600 
ppm, none of the protein peaks in the mass range of 800-12,000 m/z were found unique 
to a specific MLST or spa clonal complex.  
Moreover, none of the protein peaks were found common to all S. aureus 
isolates. Abdallah (2011) confirmed the presence of 5 protein peaks with m/z of 4,828, 
6,612, 6,428, 8,903 and 9,644 in 13 S. aureus isolates considering an error of 1500 
ppm, which were considered S. aureus discriminatory peaks by Wolters et al. 2011. 
Protein peaks listed in Table 3.1 refer to protein peaks, which are considered as 
different proteins, although they only differ by few Daltons considering an error of 600 
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ppm. We suggest that these protein peaks correspond to isomers of the same protein, 
which differ in mass due to amino acid exchange. To confirm this theory, we aligned 
proteins identified in in this study with the molecular weights of 9,620, 9,651, 9,650, 
9,617 and 9,634, via NCBInr. Although, these proteins have different accession 
numbers and were identified as DNA-binding proteins and transcriptional regulators, 
sequence similarity was 99, 98, 97 and 78%. Considering their high-occurance rates, 
we suggest the use of these proteins in MALDI-typing of S. aureus. 
In 2013, Josten et al. attempted to characterize clonal complexes of S. aureus 
using MALDI-TOF MS, by identifying proteins in mass range of 800-12,000 m/z. 
Clonal lineages were correlated to peak shifts based on the nature of mutations. 
Accordingly, different protein isoforms resulting from peak shifts were assigned to spa 
clonal complexes and MLST clonal complexes. For example, ST80 CA-MRSA strains 
are characterized by a gene mutation of S. aureus SAR1012 ORF shift, leading to a 
peak at 4,497 m/z, whereas ST88 CA-MRSA strains are characterized by a peak at 
4,511 m/z corresponding to the same SAR1012 ORF. 
 
4.2 Evaluation of Protein Identification Method 
Protein identification is mainly performed in two workflows: 2-D gel 
electrophoresis followed by PMF for each gel spot or LC MS/MS. In a previous study 
in our lab, El Hage (2012) identified 9 S. aureus proteins using the former method. 
According to the 2-D electrophoresis gel, the formic acid extraction yielded 
approximately 50 spots corresponding to one or multiple proteins. 2-D electrophoresis 
gel of El Hage (2012) can be viewed in the Appendix (Figure 7.6). 
Protein identification by coupling Nanoflow LC and MALDI-TOF MS/MS 
method is distinguished by its fast and efficient identification power of proteins; this 
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is due to the batch interpretation mode utilized in MS/MS acquisition method. Peptide 
fragments generated by MALDI-TOF MS/MS were successfully assigned to 36 
proteins by MASCOT, 16 of which belong to S. aureus. Homologues of the remaining 
proteins were found by NCBInr protein blasts. Two identified proteins with molecular 
weight of 25,571 and 40,960 Da were not matched to S. aureus homologues; we 
conclude that these 2 proteins are not yet characterized in S. aureus. Additionally, 
unassigned peptide fragments were also blasted on NCBInr.  
Twenty-three proteins identified in this study are based on MALDI-TOF 
MS/MS analysis of Nanoflow LC fractions of in-solution digest of isolate LS 16. 
Additionally, 13 proteins were identified based on MALDI-TOF M/MS analysis of 
complete in-solution digests of isolate LS 16 analyzed by MALDI-TOF MS in reflector 
mode in an array of mass ranges.  
Only one protein, virulence factor EsxA protein, with the mass of 11,029m/z 
was identified by both methods of identification; 2-D gel electrophoresis followed by 
PMF for gel spot 6 (Appendix, Figure 7.6) and Nanoflow LC MS/MS. Additionally, 
UPF0342 protein SH1117 (MW: 13348 m/z), a homologue of UPF0342 protein 
SA1663 (MW: 13301), which was identified by El Hage (2012), was identified in this 
study.  
In addition to the hour NanoFlow LC separation, tryptic-digest of isolate LS 16 
was subjected to a 5 hour Nanoflow LC separation, by increasing gradient time. 
Chromatogram of 5 hour Nanoflow LC run is shown in Appendix (Figure 7.5). As a 
result, the number of MASCOT assigned peptides decreased leading to less identified 
proteins. This phenomena can be justified by the effect of gradient length on peak 
capacity. For a complex peptide mixture with low concentration, longer gradient 
lengths produce increased peak widths, resulting in dilution of eluted peptides in 
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several MALDI target plate spots, thus resulting with a decreased MALDI-TOF MS 
signal intensity (Kocher et al., 2012). A more concentrated protein sample is 
recommended for longer NanoFlow LC separation, whereby longer separation gradient 
length was shown to share a linear relationship with number of proteins identified 
(Kocher et al., 2012).  
 
4.3 Protein Identification Audit 
Ninety-four proteins were identified in this study from formic acid extract of 
S. aureus LS 16.Proteins identified in this study range in mass from 4,061 to 117,130 
Da. The functions of proteins identified in this study were obtained from Uniprot and 
NCBI protein databases and are listed in Tables 3.5 and 3.6. Thirty-three proteins that 
were identified in this study were not assigned a molecular weight and function 
(Appendix, Table 7.5). The existence of these proteins in protein databases is due to 
automated computational analysis using gene prediction method or conceptual 
translation. 
The functions of the identified proteins varied vastly from DNA transcription 
regulation, DNA-binding, DNA-repair, kinases, proteases and few uncharacterized 
proteins. The majority of the identified proteins can be divided into four groups. The 
first group is comprised of hypothetical proteins with molecular weights of 5,864, 
4,061,  40,205,  15,331,  16,235,  29,252,  13,340,  13,302,  12,256,  13,332,  13,287 
m/z and 6 proteins with unassigned molecular weights. The second group consists of 
6 transcriptional regulators with molecular weight of 9,652, 3,4678,  9,646,  9,650,  
9,604 and 9,634 m/z. Ribosomal proteins, which constitute almost 50% of cellular 
proteins, comprise the third group. Six 30S ribosomal protein subunits with molecular 
weight of 15,128,  10,235,  10,229,  14,607 m/z and 2 proteins with unassigned 
52 
 
molecular weights were identified, in addition to 3  50S ribosomal protein subunits 
with molecular weight of 8,085 and 2 proteins with unassigned molecular weights. The 
forth group contains 4 DNA-binding protein HU with molecular weights of 9,620, 
9,626, 40,504 m/z and one protein with unassigned molecular weight. It must be noted 
that isomers of the same protein, which may be present in different isolates of S. 
aureus, could have been simultaneously identified in this study by homology. For 
example, identified transcriptional proteins with molecular weights of 9,652, 9,646, 
9,650 and 9,604 are assumed to be isomers of the same protein present in different S. 
aureus isolates; their simultaneous identification in one isolate, LS 16, is due to 
homology. 
Josten et al. (2013) proposed that hypothetical proteins in the mass range of 
800-12,000 m/z are useful for typing due to their occurrence in multiple isoforms and 
showed a correlation of their peak shift patterns and corresponding genotypic clonal 
lineages. In this study, 19 proteins were identified in this mass range. Accordingly, 
hypothetical protein pETB_p11 (MW: 5,864) and hypothetical protein (MW: 4,061) 
are considered candidates for MALDI-TOF MS typing. While ribosomal proteins are 
prominent in MALDI-TOF MS mass range 800-12000 m/z, they are  not useful for 
typing, since any knock-down introduced to ribosomal genes in studying peak shift 
patterns leads to growth arrest and alteration of protein levels (Josten et al., 2013). 
The majority of proteins identified in this study with assigned molecular 
weights and functions lie outside the MALDI-TOF MS range (800-12,000 m/z), e.g. 
39 proteins out of 59. Hence, identified proteins were examined for virulence 
characteristic, given that virulent proteins make good candidates for MALDI-TOF MS 
typing. One virulence factor identified in this study, EsxA (MW: 11,029 Da), appears 
to be a promising typable protein especially that it lies in the MALDI-TOF MS range 
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(800-12,000 m/z). Virulence factor EsxA existence in multiple drug-resistant strains 
has been proven, especially for MRSA strains. Pathogenesis of this protein is related 
to its ability to induce antibodies in S. aureus infected patients. Moreover, Virulence 
factor EsxA makes a good target antigen for new S. aureus control and prevention 
vaccines (H. Zhou et al., 2013). 
 
4.4 Evaluation of Protein Extraction Method 
 Results of correlating proteomic fingerprints to genotypic data as well as the 
identification process in this study are limited by the fact that formic acid does not 
extract the whole proteome of S. aureus. Moreover, the concentration of proteins 
extracted by formic acid is too low for analysis by NanoFlow LC. This led to absence 
of resolved peptide peaks on NanoFlow LC chromatogram. Hence, the chromatograms 
generated by ChemStation software serve to monitor the gradient only, and 
fractionation was time-based. Loading peptides on a trapping column before eluting 
them on an analytical column can overcome the low concentration challenge, since it 
allows the injection of a bigger sample volume at an elevated flowrate of 20 µL/min 
(Kocher et al., 2012). The detection of peptide peaks on NanoFlow LC chromatogram 
allows for peak-based fractionation, which will result in better MS/MS spectral quality 
and thus identification of more proteins.   
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Chapter Five 
 
Conclusion 
 
In this study, MALDI-TOF MS spectral analysis of S. aureus formic acid 
protein extracts revealed unique proteomic profiles of 25 S. aureus isolates. On the 
other hand, no correlation was possible between proteomic profiles and genotypic data. 
This is possibly due to genomic mutations leading to protein peak shifts, causing 
protein isoforms to be falsely reported as a different protein, considering an error of 
600 ppm. 
Protein identification by NanoFlow LC coupled with MALDI-TOF MS/MS is 
a powerful, fast and efficient tool. Proteins identified in this study are involved in a 
wide-range of cellular functions, including transcription regulation, DNA-binding, 
DNA-repair, kinases, proteases, and few hypothetical proteins. We propose 3 
candidate proteins for MALDI-TOF MS typing, present in MALDI-TOF MS 
detectable range of 800-12,000 m/z; 2 hypothetical proteins with molecular weight of 
5,864 and 4,061 Da and Virulence factor Esx A with molecular weight of 11,029 Da. 
The former were chosen for their existence in several isoforms and the latter was 
chosen for its virulence function. 
Further analysis of Virulence factor Esx A in large pool of S. aureus isolates 
coupled with comprehensive study of possible genomic mutations affecting its peak 
shift patterns is needed in future studies. Additionally, future work is recommended to 
proceed with a more suitable extraction protocol that allows for acquisition of 
concentrated whole protein content of S. aureus, followed by 2-Dimensional Nanoflow 
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LC MS/MS. 2-D LC allows for better peptides separation leading to an increased 
number of identified proteins.   
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Appendix 
 
 
 
Figure 7.1. BCA standard curved from which protein concentrations of isolates JS 03, JS 08, JS 10, JS 
17, JS 22, JS 50 and JS 52 were extrapolated from. 
 
 
Figure 7.2. BCA standard curved from which protein concentrations of isolates JS 54, JS 56, JS 60, JS 
61, JS 65 and JS 85 were extrapolated from. 
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Figure 7.3. BCA standard curved from which protein concentrations of isolates LS 16, LS 24, LS 34, 
LS 36, LS 57 and LS 79 were extrapolated from. 
 
 
Figure 7.4. BCA standard curved from which protein concentrations of S. epidermidis, E. coli and S. 
aureus isolate LS 16 were extrapolated. 
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Table 7.1. Trypsin-digested BSA Standard and trypsin-digested LS 16 inclusion lists 
utilized in MALDI-TOF MS/MS Interpretation method. 
Trypsin-Digested BSA 
Standards 
Trysin-Digested LS 16 
                  
400.3659 400.9892 1658.6572 
415.7304 409.2798 1692.9045 
432.0742 415.1955 1729.9358 
432.9656 437.1907 1735.8422 
463.0389 440.2151 1740.7375 
497.6936 441.0574 1880.8461 
499.1149 441.2589 1881.9633 
523.3412 459.2380 1911.9417 
541.6649 469.2853 1917.8364 
525.1186 476.8908 1918.6981 
598.0327 477.2423 1935.8468 
604.0181 482.2712 1957.7061 
642.8904 516.2645 1968.8343 
643.6831 564.1211 1973.6842 
650.7220 569.1252 1974.7076 
800.2753 671.9273 1992.7404 
816.6121 687.9029 1995.7043 
820.2831 841.3866 1996.6979 
783.8229 852.4586 2060.0527 
793.6814 854.2908 2065.0491 
821.2779 868.4467 2104.1035 
892.6742 883.3168 2224.8964 
901.2573 895.4429 2274.1482 
951.9488 912.3694 2282.5722 
962.2470 920.4929 2330.2117 
973.9276 921.3868 2363.5114 
992.3522 928.4517 2446.9229 
1081.0747 934.5127 2545.0062 
1089.4435 954.4488 2557.1691 
1108.2006 1011.3958 2558.1724 
1171.1273 1095.4201 2560.6564 
1186.8218 1306.7030 2594.1483 
1189.8515 1320.4968 2602.0212 
1214.8206 1357.5681 2603.0171 
1231.2137 1361.7376 2612.2791 
1244.5976 1378.6877 2617.0286 
1260.5962 1380.7633 2635.9960 
1268.8035 1400.5566 2636.9885 
1275.2923 1416.5301 2697.2922 
1294.2341 1435.5941 2714.0079 
1309.1736 1463.7559 2758.3713 
1197.1156 1480.7234 2797.2835 
1327.5022 1601.7405 2845.2769 
1370.8749  3372.5111 
1281.8655   
1434.5519   
1442.2743   
1447.2046   
1451.3566   
1466.6840   
1472.9178   
1477.8373   
1481.8613   
1544.1682   
1596.1889   
1612.2456   
1624.6964   
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Table 7.2. CHCA matrix exclusion list utilized in MALDI-TOF MS/MS 
Interpretation method. 
CHCA Matrix Exclusion 
       
401.0392 669.3860 
402.3249 685.3578 
413.2334 713.4137 
416.3138 714.2794 
417.0104 729.3738 
423.0239 730.4315 
428.3367 757.4382 
429.2236 758.4529 
430.3585 773.4007 
432.9860 774.4645 
438.9992 798.5811 
442.3173 801.4617 
442.9858 802.4811 
444.3380 817.4243 
445.0007 818.4971 
445.9857 826.6236 
446.9829 829.2689 
447.9823 833.0397 
448.9814 839.0522 
450.9806 842.6113 
452.9804 845.4854 
454.9711 846.5159 
460.9903 855.0192 
480.1221 861.0352 
493.2947 861.4551 
504.2826 862.5279 
506.1058 870.6411 
507.1683 870.9956 
522.0987 877.0112 
523.0917 881.2251 
524.1136 886.6346 
526.1271 889.5095 
537.3210 890.5449 
550.0951 906.5539 
552.1107 914.6673 
566.0856 930.6591 
567.0877 933.5286 
568.1056 934.5731 
570.0988 950.5784 
572.0860 958.6900 
572.4180 974.6819 
578.6308 978.5985 
581.3305 994.6036 
590.0927 1002.7141 
596.0506 1018.7061 
598.0504 1022.6254 
599.0502 1038.6269 
600.0490 1044.0508 
601.0500 1046.7365 
602.0502 1050.0660 
603.0366 1060.0129 
604.0487 1062.7255 
605.0485 1066.0282 
606.0553 1066.6468 
607.0593 1082.0056 
618.2561 1082.6546 
622.0271 1090.7610 
625.3666 1106.7473 
628.0410 1110.6747 
634.0290 1126.6728 
635.0242 1134.7675 
636.0256 1150.7644 
637.0262 1154.6993 
638.0206 1170.6979 
639.0265 1249.0397 
640.0216 1255.0361 
641.0311 1271.0158 
644.0040 1277.0366 
644.9932 1337.7323 
650.0180 1475.9990 
656.0395 1482.0018 
665.9916 2161.7256 
 2162.7834 
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Table 7.3. Fractionation pattern of trypsin-digested BSA Standard. Column 1 show BSA peptide peaks obtained from BioEngland Labs Manual 
of trypsin-digested BSA Standard. Columns A1 to B10 refer to one hour Nanoflow LC fractions analyzed by MALDI-TOF MS in reflector mode 
in mass range of 400-4,000 m/z, prior to MALDI-TOF MS/MS analysis. 
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Figure 7.5. Nanoflow LC chromatogram of trypsin-digested LS 16. Injection 
volume: 8 µL. Five hour linear gradient of 2-45% solvent B. Detection wavelength: 
210 nm. Time-based fractionation: 3min. 
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Table 7.4. Proteins identified from trysin-digested LS 16 formic acid extract by MASCOT search engine. 
  
No. Database MW (Da) ID Protein Species Database Protein Score %  Sequence Coverage Peptide mass Peptide score Peptide sequence
1 9620 DBH_STAAC DNA-binding protein HU Staphylococcus aureus SwissProt 1002 66 1378.7079  (57)  K.VQLIGFGNFEVR.E
1381.7021  (36)  K.VQLIGFGNFEVR.E + [+2.9883 at Q2]
1601.8016  (33)  K.TDLINAVAEQADLTK.K
1601.8126  (12)  K.TDLINAVAEQADLTK.K
1601.8127  (20)  K.TDLINAVAEQADLTK.K
1601.8132  43   K.TDLINAVAEQADLTK.K
1729.8931  61   K.TDLINAVAEQADLTKK.E
1735.7988  (42)  K.TDLINAVAEQADLTKK.E + [+6.0201 at L3]
1736.8186  (33)  K.TDLINAVAEQADLTKK.E + [+7.0172 at L13]
1917.9169  107   K.EAGSAVDAVFESIQNSLAK.G + [-18.0106 at N-term E]
1918.9213  (34)  K.EAGSAVDAVFESIQNSLAK.G + [-16.9902 at N15]
1934.8983  (48)  K.EAGSAVDAVFESIQNSLAK.G + [-0.9476 at E11]
1935.8981  (92)  K.EAGSAVDAVFESIQNSLAK.G
1957.8936  (50)  K.EAGSAVDAVFESIQNSLAK.G + [+21.9819 at E11]
2063.9854  13   K.KEAGSAVDAVFESIQNSLAK.G
2 13348 Y1117_STAHJ UPF0342 protein SH1117 Staphylococcus haemolyticus SwissProt 154 20 954.4895  52   K.KLFDEFR.E
1880.8973  (53)  M.AVNLYDYANQLEQALR.D
1881.9097  56   M.AVNLYDYANQLEQALR.D + [+0.9970 at E12]
3 9651 DBH1_BACHD DNA-binding protein HU-1 Bacillus halodurans SwissProt 101 17 1601.8132  43   K.TDLINAVAEQAELSK.K
1729.8931  43   K.TDLINAVAEQAELSKK.D
4 29580 Y235_STAEQ UPF0447 protein SERP0235 Staphylococcus epidermidis SwissProt 35 2 954.4895  35   K.KIVYEMR.F + Oxidation (M)
5 28960 Y3362_GEOTN UPF0447 protein GTNG_3362 Geobacillus thermodenitrificans SwissProt 35 2 954.4895  35   K.KLVYEMR.F + Oxidation (M)
6 88841 PBPA_CLOAB Penicillin-binding protein 1A Clostridium acetobutylicum SwissProt 25 1 1729.9060  25   K.QNSIQGASTITQQLIK.N
7 107792 SYI_HALOH Isoleucine--tRNA ligase Halothermothrix orenii SwissProt 15 1 1217.6532  15   K.LVMARELVDR.V + Oxidation (M)
8 40023 GCST_GEOKA Aminomethyltransferase Geobacillus kaustophilus SwissProt 15 2 1217.6532  15   R.RLVGIEMIDR.G + Oxidation (M)
9 9619 gi|488404375 transcriptional regulator Staphylococcus epidermidis NCBInr 230 66 1378.7394  61   K.VQLIGFGNFEVR.E
1414.7581  17   K.EIDIPASKVPAFK.A
1601.8132  43   K.TDLINAVAEQADLTK.K
1729.8931  61   K.TDLINAVAEQADLTKK.E
1934.8983  (48)  K.EAGSAVDAVFKSIQNSLAK.G
1935.8967  86   K.EAGSAVDAVFKSIQNSLAK.G + [+0.9970 at S12]
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No. Database MW (Da) ID Protein Species Database Protein Score % Sequence Coverage Peptide mass Peptide score Peptide sequence
10 9646 gi|446966605 transcriptional regulator Staphylococcus aureus NCBInr 182 66 1378.7394  61   K.VQLIGFGNFEVR.E
1414.7581  17   K.EIDIP AS KVP AFK.A
1601.8132  43   K.TDLINAVAEQADLTK.K
1729.8931  61   K.TDLINAVAEQADLTKK.E
1917.9169  61   K.EAGLAVDAVFES IQNS LAK.G + [- 43.9898 a t D7]
11 9650 gi|488380409 transcriptional regulator Staphylococcus NCBInr 166 52 1378.7394  61   K.VQLIGFGNFEVR.E
1601.8132  43   K.TDLINAVAEQADLTK.K
1729.8931  61   K.TDLINAVAEQADLTKK.E
1935.9030  73   K.EAGS AVDAVFES IQNS LS K.G + [- 16.0313 a t L17]
12 13302 gi|15924835 hypothetical protein SAV1845 Staphylococcus aureus NCBInr 104 20 954.4895  52   K.KLFDEFR.E
1880.8973  (53)  M.AVNLYDYANQLEQALR.E
1881.9097  56   M.AVNLYDYANQLEQALR.E + [+0.9970 a t E12]
13 12256  gi|532359921 hypothetical protein SAAG_01746 Staphylococcus aureus NCBInr 104 21 954.4895  52   K.KLFDEFR.E
1880.8973  (53)  M.AVNLYDYANQLEQALR.E
1881.9097  56   M.AVNLYDYANQLEQALR.E + [+0.9970 a t E12]
14 13332 gi|446212447 hypothetical protein Staphylococcus aureus NCBInr 104 20 954.4895  52   K.KLFDEFR.E
1880.8973  (53)  M.AVNLYDYANQLEQALR.E
1881.9097  56   M.AVNLYDYANQLEQALR.E + [+0.9970 a t E12]
15 13287 gi|379796200 hypothetical protein SAMSHR1132_16910 Staphylococcus aureus NCBInr 104 20 954.4895  52   K.KLFDEFR.E
1880.8973  (53)  M.AVNLYDYANQLEQALR.E
1881.9097  56   M.AVNLYDYANQLEQALR.E + [+0.9970 a t E12]
16 9805 gi|90962747 DNA-binding protein HU Lactobacillus salivarius NCBInr 61 13 1378.7394  61   K.VQIIGFGNFEVR.E
17 9678 gi|497173090 DNA-binding protein HU Weissella ceti NCBInr 61 34 1378.7394  61   K.VQLIGFGNFEVR.S
1935.9169  76   K.DAAS AVDAVFS S IQDS LAK.G + [+41.0265 a t S 11]
18 14040 gi|222151808 hypothetical protein MCCL_1563 Macrococcus caseolyticus NCBInr 52 5 954.4895  52   K.KIFDEFR.E
19 25571 gi|553957006 hypothetical protein Eubacterium brachy NCBInr 52 3 954.4895  52   K.KIFDEFR.E
20 9617 gi|319892463 DNA-binding protein HBsu Staphylococcus pseudintermedius NCBInr 206 52 1378.7394  80   K.VQLIGFGNFEVR.E
1381.7084  (53)  K.VQLIGFGNFEVR.E + [+1.9941 a t Q2]
1601.7924  51   K.TDLINAVAEQADLTK.K
1729.8931  80   K.TDLINAVAEQADLTKK.E + [+0.9589 a t I4]
1730.8715  (63)  K.TDLINAVAEQADLTKK.E
1917.8853  56   K.EAGLAVDAVFEAIQTS LAK.G + [- 16.0313 a t L4]
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No. Database MW (Da) ID Protein Species Database Protein Score % Sequence Coverage Peptide mass Peptide score Peptide sequence
21 9604 gi|446966606 transcriptional regulator Staphylococcus aureus NCBInr 206 52 1378.7394  80   K.VQLIGFGNFEVR.E
1381.7084  (53)  K.VQLIGFGNFEVR.E + [+1.9941 a t Q2]
1601.7924  51   K.TDLINAVAEQADLTK.K
1729.8931  80   K.TDLINAVAEQADLTKK.E + [+0.9589 a t I4]
1730.8580  (34)  K.TDLINAVAEQADLTKK.E
1730.8715  (63)  K.TDLINAVAEQADLTKK.E
1957.8710  62   K.EAGS AVDAVFEAIQNS LAK.G + [+37.9559 a t E11]
22 9634 gi|488364546 transcriptional regulator Staphylococcus NCBInr 206 52 1378.7394  80   K.VQLIGFGNFEVR.E
1381.7084  (53)  K.VQLIGFGNFEVR.E + [+1.9941 a t Q2]
1601.7924  51   K.TDLINAVAEQADLTK.K
1729.8931  80   K.TDLINAVAEQADLTKK.E + [+0.9589 a t I4]
1730.8715  (63)  K.TDLINAVAEQADLTKK.E
1918.8909  (54)  K.EAGS AVDAVFES IQKS LAK.G + [- 31.0422 a t K15]
1957.8608  61   K.EAGS AVDAVFES IQKS LAK.G + [+8.0142 a t K15]
23 44043 TGT_BACLD Queuine tRNA-ribosyltransferase Bacillus licheniformis SwissProt 14 3 1511.6504  14   R.LTS YHNLYFLLK.L
24 43882 BRPA_STRMU Biofilm regulatory protein A Streptococcus mutans serotype c SwissProt 33 1 954.6473  33   K.TTMTS LER.D + Oxida tion (M)
25 8085 RL29_STAA2 50S ribosomal protein L29 Staphylococcus aureus SwissProt 25 28 920.6347  8   K.EELFNLR.F
1464.0115  25   R.FQLATGQLEETAR.I
26 10279 Y1445_STAAN UPF0297 protein Staphylococcus aureus SwissProt 23 13 1511.9556  23   K.FDYEELP TQDVR.D
27 11029 ESXA_STAAC Virulence factor EsxA Staphylococcus aureus SwissProt 23 27 1320.8972  4   M.AMIKMS P EEIR.A + Oxida tion (M)
1735.0984  23   R.AQGEIAANWEGQAFS R.F
28 10229 RS16_STAA1 30S ribosomal protein S16 Staphylococcus aureus SwissProt 23 27 852.6048  10   K.RNP FYR.I
2059.4185  23   R.IIEQIGTYNP TS ANAP EIK.V
29 14607 RS9_STAA1 30S ribosomal protein S9 Staphylococcus aureus SwissProt 14 16 2273.5215  14   K.GNYDVLVNVHGGGFTGQAQAIR.H
30 31122 gi|557828691 2-dehydropantoate 2-reductase Exiguobacterium sp. MH3 NCBInr 56 2 954.6473  56   R.QLFDEMR.T + Oxida tion (M)
31 11271 SP5G_STAA2 Putative septation protein SpoVG Staphylococcus aureus SwissProt 39 17 1912.244 39 K.ALVS ITLDEAFVIHDLR.V
32 13150 gi|492418262 Fic family protein Eubacterium saphenum NCBInr 59 6 954.594 59 K.KIMDEMR.N + 2 Oxida tion (M)
33 40960 gi|495696491 hydrogenase expression/formation protein HypD Clostridium sp. Maddingley MBC34-26 NCBInr 59 1 826.2953  34   K.FIDEFR.N
954.3608  24   M.KFIDEFR.N
34 28880 gi|493632938 DNA repair protein RecO Lactobacillus jensenii NCBInr 56 2 826.2862  31   K.FLDEMR.R + Oxida tion (M)
954.3587  25   K.KFLDEMR.R + Oxida tion (M)
35 34894 HPRK_CLOPE HPr kinase/phosphorylase Clostridium perfringens SwissProt 38 3 1378.5558  38   R.S P EITFGMLEVR.G
36 7770 Y1696_STAAN UPF0435 protein Staphylococcus aureus SwissProt 33 25 1740.7404  34   R.LS P S EVTAIADALGQLR.H
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Table 7.5. Proteins identified in this study that were not assigned a molecular mass 
and a function. 
 
No. ID Protein 
1  gi|583105701 methionine sulfoxide reductase B, partial
2 gi|579935718 acetyl-CoA acetyltransferase, partial
3 gi|577289267 chaperonin, partial
4 gi|580848717 Oxidoreductase
5 gi|584847631 hypothetical protein U620_02608
6 gi|580689402 PTS system, ascorbate-specific IIC
7 gi|580965588 coenzyme A disulfide reductase, partial
8 gi|581796105 protein translocase subunit secA 2
9 gi|584655548 50S ribosomal protein L11
10 gi|580927722 hypothetical protein U042_02830
11 gi|582606875 hypothetical protein U343_02428, partial
12 gi|582616066 DNA topoisomerase 4 subunit B, partial
13 gi|582450771 hypothetical protein U271_01845
14 gi|582657440 DNA topoisomerase 3, partial
15 gi|580256465 50S ribosomal protein L17
16 gi|578670717 PTS system EIIBC component, partial 
17 gi|581372899 30S ribosomal protein S11, partial 
18 gi|581372899 30S ribosomal protein S11, partial
19 gi|579648211 cysteinyl-tRNA synthetase, partial
20 gi|487721653 GTP diphosphokinase
21 gi|580654011 6,7-dimethyl-8-ribityllumazine synthase
22 gi|580840478 hypothetical protein T991_02716
23 gi|582796996 hypothetical protein U433_02585
24 gi|580175801 aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
25 gi|584237569 cation:proton antiporter
26 gi|584237570 cation:proton antiporter
27 gi|580754041 transposase for insertion sequence-like element IS431mec
28 gi|584763348 kinase-associated protein B
29 gi|580255613 DNA-binding protein HU
30  gi|446015501 glycine cleavage system protein T
31 gi|580255613 DNA-binding protein HU
32 gi|579740496 queuine tRNA-ribosyltransferase
33 gi|507417608 PfkB family carbohydrate kinase
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Figure 7.6. Two dimensional electrophoresis (2-DE) representative gel of S. 
aureus isolate LS-16 performed by El Hage (2013). 
 
